fehb glp 1 coverage 2026 Hot off the press! The Centers for Medicare & Medicaid Services (CMS) will provide eligible Medicare beneficiaries access to certain GLP-1 medications for $50 per month beginning July 1, 2026, through December 31, 2027 These are the 2027 REQUIREMENTS

Conclusion As GLP-1 drugs enter the ADA-EASD guidelines as first-line drugs for type 2 diabetes, there will be a great market demand for GLP-1 drugs

Xiang, S., Gu, H., Jin, L., Thorne, R

Endogenous activation of glucagon-like peptide-1 receptor contributes to blood pressure control: role of proximal tubule Na(+)/H(+) exchanger isoform 3, renal angiotensin II, and insulin sensitivity

Aronnes clinical trial for orforglipron, the rate of adverse events (meaning health issues that happened during the trial, including things likely not related to the drug itself) appeared to be slightly lower than whats seen with injectables